Nurix Therapeutics, Inc. (NRIX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 39 days, typically, give or take 9 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Oct 13, 2026before open 43 8-K
Q2 FY2026Thu, Jul 9, 2026after close 39 8-K
Q1 FY2026Wed, Apr 8, 2026before open 39 8-K
Q4 FY2025Wed, Jan 28, 2026after close 59 8-K
Q3 FY2025Thu, Oct 9, 2025after close 39 8-K
Q2 FY2025Wed, Jul 9, 2025after close 39 8-K
Q1 FY2025Tue, Apr 8, 2025after close 39 8-K
Q4 FY2024Tue, Jan 28, 2025after close 59 8-K

What they guided beta

Q3 FY2026 "Such risks and uncertainties include, but are not limited to: (i) whether Nurix and its collaborators will be able to advance drug candidates, obtain regulatory approval and ultimately commercialize drug candidates; (ii) uncertainties related to the timing and results of preclinical studies and clinical trials; (iii) the unexpected emergence of adverse events or other undesirable side effects during clinical development; (iv) whether Nurix will be able to fund development activities and achieve development goals, including its obligations under the Nurix-Roche collaboration; (v) uncertainties " exhibit
Q2 FY2026 "Document Exhibit 99.1 [Nurix logo] Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration includes comprehensive clinical development plan in malignant hematology and enables expansion of bexobrutideg into chronic spontaneous urticaria (CSU) and multiple sclerosis (MS) Presented clinical data update at the European Hematology Association (EHA) supporti" exhibit
Q2 FY2026 "In the second fiscal quarter of 2026, Nurix earned a $2 million milestone payment from Sanofi. * Expected timing of events throughout this press release is based on calendar year quarters." exhibit
Q2 FY2026 "In addition, we expect to receive the $700 million upfront payment from Roche in the third fiscal quarter of 2026." exhibit
Q2 FY2026 "Such risks and uncertainties include, but are not limited to: (i) whether Nurix will be able to advance its drug candidates, obtain regulatory approval of and ultimately commercialize its drug candidates; (ii) uncertainties related to the timing and results of preclinical studies and clinical trials; (iii) whether Nurix will be able to fund development activities and achieve development goals; (iv) uncertainties related to the timing and receipt of payments from Nurix’s collaboration partners, including milestone payments and royalties on future product sales; (v) the impact of global business" exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NRIX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NRIX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

NRIX earnings date badge

HTML

<a href="https://veritasdata.dev/company/NRIX/"><img src="https://veritasdata.dev/embed/NRIX.svg" alt="NRIX earnings date" width="240" height="56"></a>

Markdown

[![NRIX earnings date](https://veritasdata.dev/embed/NRIX.svg)](https://veritasdata.dev/company/NRIX/)

Script

<script async src="https://veritasdata.dev/embed/NRIX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NRIX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.